Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Total Debt (2025 - 2026)

Olema Pharmaceuticals (OLMA) has 2 years of Total Debt data on record, last reported at $3.0 million in Q1 2026.

  • On a quarterly basis, Total Debt changed N/A to $3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.0 million, a N/A change, with the full-year FY2025 number at $3.0 million, changed N/A from a year prior.
  • Total Debt reached $3.0 million in Q1 2026 per OLMA's latest filing, roughly flat from $3.0 million in the prior quarter.
  • Over the last five years, Total Debt for OLMA hit a ceiling of $3.0 million in Q2 2025 and a floor of $3.0 million in Q2 2025.